NR3C1 and pancreatic adenocarcinoma: Similar to pancreatic adenocarcinoma where CDH1 (E-cadherin) is downregulated, GR activation in ILC may act as a complementary pathway to E-cadherin loss by upregulation of EMT gene expression and induction of a metastatic phenotype [46].